Atherosclerosis in Primary Antiphospholipid Syndrome: Summary of Clinical and Pathogenic Evidence

Ames PRJ^1*, Lopez LR², Matsuura E³ and Margarita A⁴

¹William Harvey Research Institute, Queen Mary University London, London, UK

²Medical Department, Director Corgenix, Inc., Broomfield, Colorado, USA

³Department of Cell Chemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan

⁴Angiology Section, Multimedica, Naples, Italy

^*Corresponding Author: Ames PRJ, William Harvey Research Institute, Queen Mary University London, London, UK, Tel: +407816225826 Email: